Related Experiment Video
Updated: Jul 5, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Borrowing from the cancer playbook: a master protocol basket trial for hard-to-heal wound therapeutics targeting
Windy Cole1, Zweli Tunyiswa2, Marissa Docter3
1Kent State University College of Podiatric Medicine, OH, US.
Objective:
Hard-to-heal wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs), remain associated with poor healing outcomes despite optimised standard care. Although classified by aetiology, these wounds share common pathophysiological features that may be amenable to mechanism-targeted therapies. This manuscript aims to describe the design, scientific rationale and statistical framework of a mechanism-driven basket trial evaluating wound therapies across multiple wound aetiologies.
Method:
This multicentre, randomised, sham-controlled clinical trial was designed under a master protocol using aetiology-specific baskets. Adults with hard-to-heal DFUs or VLUs who failed to demonstrate adequate healing during a standardised run-in period were randomised 1:1 within each basket to standard care plus active therapy or standard care plus sham. Subject and assessor blinding, harmonised standards of care, and centralised endpoint adjudication were employed. The primary endpoint within each basket was complete wound closure by 12 weeks, confirmed at two consecutive visits. Bayesian statistical methods incorporating conservatively discounted historical control data via power priors were used to enhance efficiency while preserving indication-specific inference.
Results:
The basket design enabled simultaneous evaluation of a single mechanism-targeted intervention across heterogeneous wound aetiologies while maintaining methodological rigour, regulatory alignment and interpretability. Independent analysis of each basket preserved aetiology-specific conclusions while benefiting from shared infrastructure and standardised procedures.
Conclusion:
This master-protocol basket trial adapted principles established in oncology to wound care, offering an innovative and scalable framework for evaluating therapies targeting shared biological barriers to healing. The approach may accelerate evidence generation and inform future clinical development strategies in hard-to-heal wounds.
More Related Videos
06:13A Tool to Automatically Create Stable and Reproducible Cell-free Gaps for Improving the Reliability of Cell Wound Healing Assay
Published on: October 4, 2024
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...